Prostate Specific Antigen (psa) - Bioanalytical Research

Relevant Publications

Development of a bioluminescent homogenous nanobody-based immunoassay for the detection of prostate-specific antigen (PSA).

Issue Release: 2024

Analysis of risk factors for disease progression after salvage radiation therapy with androgen deprivation therapy in prostate cancer patients who have prostate-specific antigen persistence after radical prostatectomy.

Issue Release: 2024

Decision regret after prostate biopsy for prostate cancer diagnosis: a Korean multicenter cohort study.

Issue Release: 2024

The pros and cons of nucleic acid-amplified immunoassays-a comparative study on the quantitation of prostate-specific antigen with and without rolling circle amplification.

Issue Release: 2024

Electrolyte-gated amorphous IGZO transistors with extended gates for prostate-specific antigen detection.

Issue Release: 2024

Transcriptome-Wide Association Analysis Identifies Candidate Susceptibility Genes for Prostate-Specific Antigen Levels in Men Without Prostate Cancer.

Issue Release: 2024

A phase II study (AARDVARC) of AZD4635 in combination with durvalumab and cabazitaxel in patients with progressive, metastatic, castration-resistant prostate cancer.

Issue Release: 2024

Established and emerging liquid biomarkers for prostate cancer detection: A review.

Issue Release: 2024

A dynamic online nomogram predicting prostate cancer short-term prognosis based on F-PSMA-1007 PET/CT of periprostatic adipose tissue: a multicenter study.

Issue Release: 2024

Prostate cancer with elevated free prostate-specific antigen density: A case report.

Issue Release: 2024

Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe.

Issue Release: 2024

Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer.

Issue Release: 2024

MRI-guided Cryoablation of Prostate Cancer Lymph Node Metastasis.

Issue Release: 2024

PRIORITI: Phase 4 study of triptorelin or active surveillance in high-risk prostate cancer.

Issue Release: 2024

PSA doubling time 4.65 months as an optimal cut-off of Japanese nonmetastatic castration-resistant prostate cancer.

Issue Release: 2024

Impact of frozen section on long-term outcomes in robot-assisted laparoscopic prostatectomy.

Issue Release: 2024

Associations of systemic immune-inflammation index with high risk for prostate cancer in middle-aged and older US males: A population-based study.

Issue Release: 2024

Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) study: ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapy.

Issue Release: 2024

XRCC1 and XPD polymorphisms: clinical outcomes and risk of prostate cancer in Bangladeshi population.

Issue Release: 2024

Analysis of Molecular Imaging and Laboratory Baseline Biomarkers in PSMA-RLT: Whole-Body Total Lesion PSMA (TLP) Predicts Overall Survival.

Issue Release: 2024

What is Bioanalytical Reporting?

What is Nuclear Magnetic Resonance (NMR)?

What are Biochemical Assays?

What are the Limitations of the Widmark Formula?

What is Nano CE?

What Role Does Bioanalytical Science Play?

What Role Do Genetic Polymorphisms Play?

What are some key techniques used in Molecular Biology for Bioanalytical purposes?

What are the Future Prospects?

How Are Biomarkers Used in Nutritional Studies?

Partnered Content Networks

Relevant Topics